Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1973 1
1976 1
1978 1
1980 2
1981 1
1985 2
1986 2
1987 2
1988 1
1989 1
1990 1
1992 1
1993 2
1994 7
1995 4
1996 4
1997 16
1998 8
1999 10
2000 7
2001 17
2002 13
2003 13
2004 11
2005 18
2006 15
2007 22
2008 10
2009 15
2010 15
2011 12
2012 11
2013 13
2014 17
2015 27
2016 20
2017 17
2018 17
2019 35
2020 31
2021 43
2022 48
2023 56
2024 25

Text availability

Article attribute

Article type

Publication date

Search Results

554 results

Results by year

Filters applied: . Clear all
Page 1
Nanocarriers for natural polyphenol senotherapeutics.
Joma N, Bielawski PB, Saini A, Kakkar A, Maysinger D. Joma N, et al. Aging Cell. 2024 Apr 29:e14178. doi: 10.1111/acel.14178. Online ahead of print. Aging Cell. 2024. PMID: 38685568 Free article. Review.
Disordered clock protein interactions and charge blocks turn an hourglass into a persistent circadian oscillator.
Jankowski MS, Griffith D, Shastry DG, Pelham JF, Ginell GM, Thomas J, Karande P, Holehouse AS, Hurley JM. Jankowski MS, et al. Nat Commun. 2024 Apr 25;15(1):3523. doi: 10.1038/s41467-024-47761-z. Nat Commun. 2024. PMID: 38664421 Free PMC article.
To determine the functionality of these disordered regions, we applied a synthetic peptide microarray approach to the disordered clock protein FRQ in Neurospora crassa. We identified residues required for FRQ's interaction with its partner protein FRH, the mutation …
To determine the functionality of these disordered regions, we applied a synthetic peptide microarray approach to the disordered clock prote …
Effect of family resilience on subjective well-being in patients with advanced cancer: the chain mediating role of perceived social support and psychological resilience.
Yang Y, He F, Li D, Zhao Y, Wang Y, Zhang H, Qiao C, Cui Y, Lin L, Guan H. Yang Y, et al. Front Psychol. 2024 Apr 4;14:1222792. doi: 10.3389/fpsyg.2023.1222792. eCollection 2023. Front Psychol. 2024. PMID: 38638678 Free PMC article.
The current study investigates the pathways to improve patients' sense of well-being from the family, social, and individual levels, that is to say, it investigates the mediating roles of comprehending social support as well as psychological resilience in the relationship between …
The current study investigates the pathways to improve patients' sense of well-being from the family, social, and individual levels, that is …
Phosphorylation, disorder, and phase separation govern the behavior of Frequency in the fungal circadian clock.
Tariq D, Maurici N, Bartholomai BM, Chandrasekaran S, Dunlap JC, Bah A, Crane BR. Tariq D, et al. Elife. 2024 Mar 25;12:RP90259. doi: 10.7554/eLife.90259. Elife. 2024. PMID: 38526948 Free PMC article.
Although FRQ phosphorylation favors LLPS, LLPS feeds back to reduce FRQ phosphorylation by CK1 at higher temperatures. ...In this process, a solution containing molecules of FRQ separates into two distinct components (known as phases), one of which contains …
Although FRQ phosphorylation favors LLPS, LLPS feeds back to reduce FRQ phosphorylation by CK1 at higher temperatures. ...In t …
Trastuzumab deruxtecan for human epidermal growth factor receptor 2-low advanced or metastatic breast cancer: recommendations from the Japanese Breast Cancer Society Clinical Practice Guidelines.
Hattori M, Honma N, Nagai S, Narui K, Shigechi T, Ozaki Y, Yoshida M, Sakatani T, Sasaki E, Tanabe Y, Tsurutani J, Takano T, Saji S, Masuda S, Horii R, Tsuda H, Yamaguchi R, Toyama T, Yamauchi C, Toi M, Yamamoto Y. Hattori M, et al. Breast Cancer. 2024 May;31(3):335-339. doi: 10.1007/s12282-024-01550-0. Epub 2024 Mar 4. Breast Cancer. 2024. PMID: 38433181 Free PMC article.
In the recent edition of these guidelines, we addressed a new clinical question 34 (CQ 34, systemic treatment part) "Is trastuzumab deruxtecan recommended for patients with unresectable or metastatic HER2-low breast cancer?" and a new future research question 7 (FRQ 7, pat …
In the recent edition of these guidelines, we addressed a new clinical question 34 (CQ 34, systemic treatment part) "Is trastuzumab deruxtec …
554 results